6509--Fenofibrate Tablets (VA-25-00066469)

The Department of Veterans Affairs National Acquisition Center is soliciting offers for Fenofibrate Tablets through solicitation number 36E79725R0047. The procurement seeks to establish a supply contract for four line items of Fenofibrate Tablets in two strengths (48mg and 145mg) with package sizes of 90 and 500 tablets per bottle. Offerors must be FDA-compliant, provide detailed manufacturing information including unique 11-digit National Drug Code numbers, and meet specific packaging requirements including safety caps and bar coding standards. The solicitation requires offerors to submit pricing for all line items and option years while including a 0.5% Cost Recovery Fee. Offers are due by July 10, 2025 at 2:30 PM CT, and the procurement is structured as a single aggregate award opportunity.

This opportunity does not utilize any set-aside designation and will serve multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract structure includes a base year plus four one-year option periods, with estimated annual quantities ranging from 7,007 to 125,138 bottles across all participating agencies. Distribution will be handled through Pharmaceutical Prime Vendor programs, with McKesson Corporation identified as one of the prime vendor partners. The solicitation falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, though it is categorized under PSC 6509 for Drugs and Biologicals, Veterinary Use. The contract will support pharmaceutical distribution across federal healthcare systems serving veterans, military personnel, federal inmates, and Native American populations.